10x Genomics (TXG) Acquisitions (2021 - 2022)
10x Genomics' (TXG) quarterly Acquisitions came in at $2.5 million in Q4 2022, up 66.67% quarter-over-quarter from $1.5 million in Q3 2022.
Powered by 
Analysis
10x Genomics (TXG) Acquisitions (2021 - 2022) Analysis & Trends
10x Genomics has disclosed Acquisitions across 2 years of filings, most recently posting $2.5 million for Q4 2022.
- In Q4 2022, Acquisitions changed N/A year-over-year to $2.5 million; the TTM figure through Dec 2023 stood at $4.0 million (changed 0.0% YoY), while the FY2022 annual figure was $4.0 million, down 26.62% from the prior year.
- Acquisitions came in at $2.5 million for Q4 2022 at 10x Genomics, up from $1.5 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $5.5 million in Q1 2021 to a low of $1.5 million in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | - |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | 950.00 Mn |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | 2.00 Mn |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | - |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | - |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | 1.50 Mn |
| Mar 31, 2021 | 5.45 Mn |